A carregar...

Mechanism-based population pharmacokinetic modelling in diabetes: vildagliptin as a tight binding inhibitor and substrate of dipeptidyl peptidase IV

AIMS: To assess the pharmacokinetics of vildagliptin at different doses and build a mechanism-based population model that simultaneously describes vildagliptin pharmacokinetics and its effects on DPP-4 activity based on underlying physiology and biology. METHODS: Vildagliptin concentrations and DPP-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Landersdorfer, Cornelia B, He, Yan-Ling, Jusko, William J
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Science Inc 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3370343/
https://ncbi.nlm.nih.gov/pubmed/22442826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2011.04108.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!